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Summary Radiofrequency ablation has been applied to treat hepatocellular carcinoma, with
favorable therapeutic outcomes. Nevertheless, practitioners have approached radiofrequency
ablation with some reluctance due to the difficulty of identifying isoechoic tumors and
recurrent tumors. The aim of the present study is to investigate the efficacy of Real-time
Virtual Sonography to treat hepatocellular carcinoma difficult to detect by conventional ultra-
sonography. Real-time Virtual Sonography is a system generating multiplanar reconstruction
images in real-time using the Hitachi medico EUB-8500 equipped with a probe. The system
included following components: 1) digital imaging and communications in medicine (DICOM)
data from dynamic CT, 2) a magnetic field generator to match the multiplanar reconstruction
image on the monitor and the actual ultrasonography image, 3) the cross section with the
tumor displayed as a multiplanar reconstruction image. Total twenty-five nodules of twenty-
one patients underwent radiofrequency ablation monitored by Real-time Virtual Sonography.
All nodules difficult to detect via conventional ultrasonography were clearly visualized in real-
time. The average nodule diameter was 2.4 ± 1.6 cm, and punctures and coagulation were
performed an average of 2.2 and 3 times per session. Dynamic CT after session confirmed
effective coagulation of each nodule. In conclusion, this study demonstrates that the present
system is capable of effectively and accurately treating tumors difficult to detect by
conventional ultrasonography.
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Introduction
The incidence of HBV or HCV-associated viral hepatitis
is increasing [1], along with the incidence of hepatocellular
carcinoma (HCC). However, advances in diagnostic imaging
techniques such as ultrasonography, computed tomography
(CT), and magnetic resonance imaging (MRI) now enable
early detection and diagnosis of HCC [2]. In recent years,
HCC detected by these diagnostic imaging techniques
has been treated locally by radiofrequency ablation (RFA)
and other techniques, with favorable therapeutic outcomes
comparable to hepatectomy [3, 4]. However, abdominal ultra-
sonography does not always provide precise guidance in
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identifying isoechoic tumors, tumors recurring locally in
areas treated with lipiodol following transarterial chemo-
embolization (TACE), or tumors recurring in areas treated
by RFA or percutaneous ethanol injection (PEI) procedures.
We have recently utilized the approaches which involved
preparing multiplanar reconstruction (MPR) images that
matched ultrasonography images of lesions and expected
puncture routes on a workstation. MPR images were re-
constructed by matching ultrasonography images and CT data
(digital imaging and communications in medicine (DICOM)
data) obtained by prior CT during arterial portography
(CTAP) and CT during hepatic arteriography (CTHA) [5],
followed by more accurate coagulation based on scans of
target areas while referring to the relative positions of
surrounding vessels and organs shown of the images. One
problem with this technique is that MPR images are prepared
in advance, and critical discrepancies can arise in scans of
intercostal spaces due to axial rotation of a probe between
the MPR and ultrasound images. Seeking to resolve this
problem, we investigated the feasibility of Hitachi Medical
Real-time Virtual Sonography (RVS), a system that generates
MPR images in real-time, as a probe scans over target areas.
Materials and Methods
Subjects
Among consecutive subjects who admitted to Saga
Medical School with diagnosed HCC from January 2004 to
January 2005, candidates for unresectable invasive therapy
were eligible for enrollment after informed consent was
obtained. Diagnosis was confirmed by needle biopsy or by
plural imaging techniques including ultrasonography, dynamic
CT, dynamic MRI, and super paramagnetic iron oxide MRI.
Subjects with up to 3 nodules less than 3 cm in diameter
were excluded from this study and received transarterial
chemo-embolization. CTAP/CTHA was performed for all
enrolled subjects; 1) to confirm HCC which showed low
density tumor with CTAP, high density tumor with early
phase CTHA, and low density tumor with corona enhance-
ment with delayed phase CTHA, 2) to survey multi-centric
occurrence of HCC, and 3) to confirm intrahepatic tumor
staging [6].
Therapeutic system and procedures
The therapeutic system used comprised the Hitachi
Medico Digital Ultrasound EUB-8500 and Hitachi Medico
Workstation RVS (Hitachi Medico. co. Tokyo, Japan), which
generate real-time MPR images. The RVS, a revolutionary
real-time MPR imaging machine that supports ultrasono-
graphy diagnosis developed by Hitachi Medico, consists of a
small magnetic sensor attached to a convex-shaped EUB-8500
probe. This magnetic sensor precisely and consistently captures
changes in magnetic fields generated by the generator placed
on the left flank of a patient and detects the changes in the
location, direction, and rotation of the probe scanning of the
patient. The RVS instantaneously processes changes in
positional information detected by the magnetic sensor and
generates real-time MPR images matching cross-sectional
images of the abdomen captured by the probe (Fig. 1).
The actual procedure is as follows: 1) CTAP/CTHA was
performed, followed by transfer of volume data (DICOM
data) to the RVS. CTAP data was used because CTAP
detects portal and hepatic veins, which was captured by
ultrasonography. The positional relationship of a tumor to
these vessels is critical for identifying lesions which ultra-
sonography cannot detect. 2) A magnetic field generator is
placed on the left flank of a patient. 3) The sagittal section of
the left hepatic lobe is first captured using a probe equipped
with a magnetic sensor. The xiphoid process serves as the
initial reference point. When a CT image with the tip of the
xiphoid process captured before MPR processing matches
the tip of the xiphoid process on the actual abdominal ultra-
sound image, the RVS begins continuous generation of MPR
images in real-time, displaying the images on the work-
station monitor. 4) A cross-sectional image showing the
tumor is displayed with the MPR image, and both images are
corrected based on neighboring portal and hepatic veins; and
5) the tumor is then punctured and coagulated under RVS-
guidance in the conventional technique. The RFA device
used in the methods were Cool-tip electrode with a 2- or 3-
cm exposed tip and a radiofrequency generator (Radionics,
Burlington, MA). The procedures were each performed by
one of three experienced RFA physicians (Y.E, T.Y, and T.M).
Efficacy assessment
Abdominal dynamic CT was performed on all patients
approximately 3 days and 1 month after the treatment for
evaluation after RFA. Complete response was confirmed by
dynamic CT showed widely low density area with sufficient
safety margin.
Results
In this study, 21 patients included seven men and fourteen
women were enrolled (Fig. 2). Their mean age was 73 years
old (range 64–84 years old). All patients were positive
for the hepatitis C virus antibody. Eighteen patients had
Child–Pugh class A cirrhosis and 3 patients had class B
cirrhosis (mean Child–Pugh score 5.8 ± 0.8). Twenty five
nodules in 21 patients were diagnosed HCC (23 nodules
were diagnosed by CTAP/CTHA, 2 nodules were diagnosed
with needle biopsy as well differentiated HCC. RFA was
performed using the present system to treat all 25 nodules in
21 patients. Of the 25 nodules, 11 nodules were tumors with
unclear margins, as seen in representative ultrasonography
images shown in Fig. 3, 5 were tumors arising in the vicinityH. Kawasoe et al.
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of areas coagulated following radiofrequency ablation; 4
were tumors that could not be fully identified due to their
position beneath the diaphragm; 4 were viable tumors
emerging following TACE in areas affected by posterior
acoustic enhancement of lipiodol deposition; and 1 was a
recurrent tumor located at a resection stump following
hepatectomy (Table 1).
In all cases, conventional ultrasonography failed to detect
the entire lesion accurately. In contrast, the current RVS
made it possible to accurately and conveniently ascertain
the extent of nodules. RFA was performed using the
present system to treat all 25 nodules in 21 patients. The
Fig. 1.  Summary of the Real-time Virtual Sonography system (Hitachi Medical, partially modified). Step 1: Using the xiphoid process
as a reference point, match positional coordinates for positional synchronization. Step 2: Gather positional information from
the magnetic sensor attached to the probe. Step 3: An MPR image matching the positional information from the probe is
reconstructed based on CT volume data and displayed on the workstation monitor.
A: Magnetic field generator. B: Magnetic sensor. C: Probe. D: Magnetic position detecting unit.
Fig. 2.  Flow diagram of subjects enrollment. TACE, transarterial chemo-embolization; RFA, radiofrequency ablation; PEI, percutaneous
ethanol injection.Real-Time Virtual Sonography for HCC
Vol. 40, No. 1, 2007
69
average tumor diameter was 2.4 ± 1.6 cm, and punctures and
coagulation were performed an average of 2.2 and 3 times
per session. Dynamic CT for evaluation after RFA showed
widely low density area with sufficient safety margin and
confirmed that each tumor had been effectively coagulated.
CTAP image and CTHA images before RFA are shown
in Fig. 4. HCC is seen in the area with a reduced portal
flow in segment 4 (arrow head) on CTAP (Fig. 4A), the
area with high hepatic arterial flow on early-phase CTHA
(Fig. 4B), and corona enhancement on delayed-phase CTHA
(Fig. 4C). Fig. 4D shows tumor accurately coagulated under
RVS-guidance.
Discussion
In recent years, HCC has been treated effectively by
combining various therapeutic techniques. Among these
techniques, use of percutaneous RFA in particular has
grown, with therapeutic outcomes for HCC of less than 3 cm
in diameter comparable to PEI therapy or hepatectomy [3,
Fig. 3.  Images displayed on the workstation monitor. Moving images are displayed in real-time. Upper left: An MPR image recon-
structed during scanning. Arrow head: Hepatocellular carcinoma detected by CTAP. Upper right: Actual ultrasound image. The
hepatocellular carcinoma was isoechoic and difficult to detect. Lower: A reconstructed image of the trunk region based on CT
volume data. The arrow indicates the location of probe scanning ascertained from positional information gathered by the
magnetic sensor (arrow). The cross section of this area was reconstructed as an MPR image. MPR: multiplanar reconstruction,
CTAP: CT during arterial portography.
Table 1. Characteristics of 25 tumors which were difficult to identify via conventional ultrasonography
Characteristics of tumors n
Detection (yes/all)
CTAP/CTHA US RVS
(1) Unclear margins, as seen in ultrasound images 11 11/11 0/11 11/11
(2) Arising in the vicinity of areas coagulated 
following radiofrequency ablation 5 5/5 0/5 5/5
(3) Could not be fully identified due to position 
beneath the diaphragm 4 4/4 0/4 4/4
(4) Viable tumor emerging following transarterial 
chemoembolization in areas affected by posterior 
acoustic enhancement of lipiodol deposition
4 4/4 0/4 4/4
(5) Recurrent tumor located at a resection stump 
following hepatectomy 1 1/1 0/1 1/1H. Kawasoe et al.
J. Clin. Biochem. Nutr.
70
7–9]. A recent study shown RFA for HCC is a definitive
treatment as a bridge to liver transplantation [10]. But in
recent years, treatment has increasingly tackled lesions
recurring in the vicinity of areas treated by RFA or TACE
[11]. Such recurrent lesions and isoechoic tumors are often
difficult to identify by conventional B-mode ultrasonography
[12], and imaging success depends heavily on operator’s
skill [13]. Techniques used to improve the effectiveness of
this approach include use of coded-harmonic images and
ultrasonographic contrast media; deliberate injection of
pleural or peritoneal fluid to aid imaging; and CT-guided
punctures [14]. However, each of these methods involves
certain drawbacks. We have recently utilized the approaches
which involved preparing MPR images that matched ultra-
sonography images of lesions and expected puncture routes
on a workstation. MPR images were reconstructed by prior
CT data (DICOM data). Discrepancies can arise between
MPR and ultrasound images due to axial rotation of a probe
for scans of intercostal spaces. RVS could solve this problem
by real-time adjustment based on neighboring portal and
hepatic veins, and shapes of the liver bed.
While reports have referenced therapeutic systems that
generate MPR images like the RVS items [15] are unable to
reconstruct accurate and real-time MPR imaging capable of
keeping pace with probe-scanning, the current RVS we
employed makes it possible to accurately and conveniently
ascertain the extent of nodules which were difficult to
identify by conventional ultrasonography. RVS also clearly
indicates the location of the lungs, intestines, or mesentery,
minimizing the risk of inducing pneumothorax, puncturing
the intestinal canal, or burning other organs, even when
tumors are located beneath the diaphragm or in the liver
bed [16]. These qualities make it an extremely effective
approach for treating liver tumors, including cases of HCC,
which are not readily identifiable by conventional ultra-
sonography. Several previous reports indicated that the HCC
nodule, which was not detected by conventional B-mode and
was detected only by CTAP/CTHA, was detected during
surgical operation [17–19]. As indicated in this study, RVS
might be one of modalities which recovered defect of
conventional B-mode and RVS enabled accurate detection for
a target, which supported appropriate therapeutic approach
to the HCC nodule.
Some limitations in current RVS systems are as follows.
Fig. 4.  CT during arterial portography (CTAP) and CT during hepatic arteriography (CTHA) of pre-treatment and dynamic CT of post-
treatment of HCC. A: CTAP. Area with a absence of portal flow is shown in segment 4 (arrow head). B: Early-phase CTHA.
High hepatic arterial flow and enhanced hepatocellular carcinoma. C: Delayed-phase CTHA. Corona enhancement around the
tumor. D: Tumor accurately coagulated under RVS guidance.Real-Time Virtual Sonography for HCC
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First, RVS requires close synchronization of MPR and ultra-
sound images, making it essential to obtain CT data on
portal and hepatic veins, which makes it necessary to
investigate RVS systems in patients in whom dynamic CT or
dynamic MRI is contraindicated due to issues such as
contrast medium allergies or renal dysfunction. Second, the
synchronized image on RVS is not perfectly the same slice
but the discrepancy in most cases can be adjusted with
neighboring portal and hepatic veins, and shapes of the liver
bed. In one case in this study, there were no vessels which
made reference to detect precise position. Third, it is
difficult to lead accurately RFA needles to nodules in some
cases, even when RVS can reveal the position of tumor.
Because of distortion of the liver, we experienced three
nodules those were needed to re-insert for a sufficient
puncture. As a result, effective ablations were performed in
all cases in this study.
In our current study, the outcome obtained from these
patients using RVS systems showed favorable clinical course
in spite of these limitations in relatively small sample size.
Further study with control group in larger number is required.
In conclusion, our study demonstrates that the RVS system is
capable of effectively and accurately percutaneous coagulation
for HCC which is difficult to detect by conventional ultra-
sonography.
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